Retrospective Treatment Pattern Survey for the Patient With and Without History of Stroke - Full Text View

Sponsored by:	AstraZeneca
Information provided by:	AstraZeneca
ClinicalTrials.gov Identifier:	NCT00785057

Purpose

This study will compare hypertension treatment pattern of stroke patients with non-stroke patients receiving medical care from outpatient clinics at neurology specialty centers in Korea. It will evaluate target BP achievement rate in patients with stroke compared to patients without stroke and investigate factors affecting BP target goal efficacy in these patients.

Condition
Hypertension

MedlinePlus related topics: High Blood Pressure

U.S. FDA Resources

Study Type:	Observational
Study Design:	Cohort, Retrospective
Official Title:	A Retrospective, Multi Centre, Non-Interventional, Observational Study to Compare Treatment Pattern and Factors That Affect BP Control in Patients With and Without Stroke

Further study details as provided by AstraZeneca:

Primary Outcome Measures:

Blood pressure, History of stroke, Antihypertensive medication [ Time Frame: After collecting all Patient Record Form. ]

Secondary Outcome Measures:

Blood pressure, History of stroke, antihypertensive medication, Classification of stroke, Risk factors, Concomitant medication, etc. [ Time Frame: After collecting all Patient Record Form. ]

Biospecimen Retention: None Retained

Biospecimen Description:

Estimated Enrollment:	1000
Study Start Date:	November 2008
Estimated Study Completion Date:	May 2009

Groups/Cohorts
1 Hypertension patients with history of stroke
2 Hypertension patients without history of stroke

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No
Sampling Method:	Non-Probability Sample

Study Population

Hypertension outpatients coming to the Neurology Department

Criteria

Inclusion Criteria:

Outpatients attending neurology specialty centers, either with or without history of stroke, receiving hypertension medication

Exclusion Criteria:

Secondary hypertension patients
Patients not receiving hypertension medication

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00785057

Locations

Korea, Republic of
Research Site
Busan, Korea, Republic of
Research Site
Deagu, Korea, Republic of
Research Site
Deajeon, Korea, Republic of
Research Site
Kwangju, Korea, Republic of
Research Site
Seoul, Korea, Republic of
Korea, Republic of, Gyeonggi
Research Site
Goyang, Gyeonggi, Korea, Republic of
Research Site
Sungnam, Gyeonggi, Korea, Republic of
Korea, Republic of, Kangwon
Research Site
Wonju, Kangwon, Korea, Republic of

Sponsors and Collaborators

AstraZeneca

Investigators

Study Director:

Joonwoo Bahn

Astrazenca Korea medical dept.

More Information

Study ID Numbers:	NIS-CKR-DUM-2008/4
Study First Received:	November 4, 2008
Last Updated:	November 26, 2008
ClinicalTrials.gov Identifier:	NCT00785057
Health Authority:	Korea: Food and Drug Administration

Keywords provided by AstraZeneca:

Hypertension
Stroke
Neurology

JNC7
2007 ESH-ESC guidelines
survey

Study placed in the following topic categories:

Cerebral Infarction
Stroke
Vascular Diseases
Hypertension

Additional relevant MeSH terms:

Cardiovascular Diseases

ClinicalTrials.gov processed this record on January 16, 2009